Medical Expert - Christopher A.  Sullivan, MD

Area of Expertise: Otolaryngology
Media Contact: Marguerite Beck marbeck@wakehealth.edu
Media Office: 336-716-2415 Media Mobile: 336-480-8599
Patient Contact: Health On-Call® 1-800-446-2255

Christopher A.  Sullivan, MD

Assistant Professor of Otolaryngology

Sullivan is a national pioneer in the endoscopic management of hypopharyngeal stenosis after organ-sparing chemoradiation therapy for head and neck cancer, and the lead investigator of a seminal study that employed the TREAD (transgastric retrograde esophagoscopy with anterograde dilatation) technique in successful rehabilitation of swallowing. He is now involved in the development of a bioabsorbable, drug-eluding stent for esophageal stenosis. Sullivan is investigating the use of wound-closing sutures that inhibit the formation of collagen, and earlier this year published his success in reducing scar tissue in rodent models. He is also involved in a promising study to restore salivary gland function in oral cancer patients. Sullivan is listed in "Best Doctors in America."

Keywords

Head and neck surgical oncology, reconstruction and rehabilitation, surgery of thyroid and parathyroid glands, salivary gland tumors, regeneration of salivary gland function

Related Experts

J. Dale Browne, MD, FACS
James A. Harrill Professor and Chairman of Otolaryngology
Area of Expertise: Otolaryngology

Listed for several years in "Best Doctors," Dr. Browne recently completed and published an extensive review of arterovenous dural fistulas involving the skull base treated at Wake Forest Baptist. His international collaboration on the transotic approach to the cerebellopontine angle with


USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.